Какова цена за Energenesis Biomedical CO.,LTD. (6657)

Цена за Energenesis Biomedical CO.,LTD. (6657) Это $0.97305026

Какова рыночная капитализация для Energenesis Biomedical CO.,LTD. (6657)

Рыночная капитализация для Energenesis Biomedical CO.,LTD. (6657) Это $85.54M

Energenesis Biomedical CO.,LTD. (6657) История Цен

Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.

Год	Результативность
2026 (TTM)	2.62%
2025	-16.78%
2024	-17.88%
2023	0.00%

Год

Результативность

2026 (TTM)

2.62%

2025

-16.78%

2024

-17.88%

2023

0.00%

Компания	Цена акций	Изменение 1г%	Страна
Vertex Pharmaceuticals Incorporated VRTX.US	$547.71	38.62%	US
Argenx SE ARGX.US	$1.04K	58.06%	NL
Moderna, Inc. MRNA.US	$145.75	437.43%	US
CSL Limited CSL.AX	$118.70	-15.60%	AU
Lonza Group AG LONN.SW	$770.19	8.98%	CH

Компания

Цена акций

Изменение 1г%

Страна